HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Peter Raivio Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raivio, P. Articles by Petäjä, J. Search for Related Content PubMed PubMed Citation Articles by Raivio, P. Articles by Petäjä, J. Related Collections Extracorporeal circulation

---

Reviews

Thrombin in Myocardial Ischemia-Reperfusion During Cardiac Surgery

^a Department of Cardiothoracic Surgery, Helsinki University Central Hospital, Helsinki, Finland
^b Department of Coagulation Disorders, Helsinki University Central Hospital, Helsinki, Finland
^c Laboratory Division (HUSLAB), Helsinki University Central Hospital, Helsinki, Finland
^d Department of Pediatrics, Helsinki University Central Hospital, Helsinki, Finland

^_* Address correspondence to Dr Raivio, Department of Cardiothoracic Surgery, Helsinki University Central Hospital, PO Box 340, Helsinki, FI-00029 HUS, Finland (Email: peter.raivio{at}hus.fi).

Thrombin is a multifunctional protease with procoagulant, pro-inflammatory, and pro-apoptotic effects. Thrombin has direct potentially adverse effects on the endothelium and on cardiomyocytes, which are independent of its procoagulant effects, and it has emerged as a possible mediator of ischemia-reperfusion injury. Several lines of experimental evidence specifically implicate thrombin to be involved in myocardial ischemia-reperfusion injury. Cardiopulmonary bypass increases thrombin generation progressively, but reperfusion after myocardial ischemia induces an additional distinct and rapid increase in thrombin generation. Clinical studies have shown that thrombin formation during cardiac surgery, especially during myocardial reperfusion, is involved with myocardial damage and impaired hemodynamic recovery. Therefore, strategies to improve thrombin control during cardiopulmonary bypass might be beneficial.

This article has been cited by other articles:

				R. M. Sniecinski and W. L. Chandler Review Articles: Activation of the Hemostatic System During Cardiopulmonary Bypass Anesth. Analg., December 1, 2011; 113(6): 1319 - 1333. [Abstract] [Full Text] [PDF]